{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T20:37:56Z","timestamp":1783802276018,"version":"3.55.0"},"reference-count":22,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder characterized by hyperandrogenism, ovulatory dysfunction, and an increased prevalence of metabolic syndrome. Clusterin (CLU), a chaperone protein induced by cellular stress and known to play roles in inflammation, oxidative stress, and lipid metabolism, may be associated with the metabolic abnormalities observed in patients with PCOS. The purpose of this current study is to investigate serum CLU levels and their link with endocrine, biochemical, and metabolic parameters, such as metabolic syndrome, among women with PCOS. Methods: This cross-sectional study included 40 women aged 18\u201330 with PCOS diagnosed according to the Rotterdam criteria and 40 age- and BMI-matched healthy controls. Demographic data, Ferriman\u2013Gallwey scores, hormonal and metabolic parameters (including TSH, prolactin, 17-OH progesterone, total testosterone, insulin, AMH, HOMA-IR, and serum CLU levels), and ultrasonographic ovarian morphology were assessed. Statistical analyses, including ROC and logistic regression, were performed. Results: Women with PCOS had higher follicle counts, Ferriman\u2013Gallwey scores, LH\/FSH ratios, fasting insulin levels, HOMA-IR, triglycerides, and systolic blood pressure than controls, whereas menstrual cycle frequency and HDL levels were lower (all p &lt; 0.05). Serum CLU concentrations were markedly higher in the PCOS cohort. In the PCOS population, CLU showed positive relationships with the Ferriman\u2013Gallwey score, fasting glucose, fasting insulin, HOMA-IR, and triglycerides, and a negative correlation with HDL. CLU levels were significantly higher in women with metabolic syndrome in the PCOS cohort compared to those without. In logistic regression analysis, CLU, AMH, and the LH\/FSH ratio emerged as independent predictors of PCOS. Furthermore, CLU remained an independent predictor of metabolic syndrome in the PCOS cohort. In ROC analysis, CLU demonstrated strong diagnostic efficacy in detecting both PCOS (AUC = 0.834) and metabolic syndrome in patients with PCOS (AUC = 0.804). Conclusions: Our results show that serum CLU is higher in women with PCOS and is associated with the clinical and metabolic features peculiar to patients with PCOS. CLU was found to distinguish between patients with PCOS and healthy women and demonstrated a strong association with the presence of metabolic syndrome within the PCOS group. Overall, these findings suggest that CLU may be a valuable auxiliary biomarker for detecting women with PCOS at risk for metabolic disturbances.<\/jats:p>","DOI":"10.3390\/diagnostics16010167","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T10:03:48Z","timestamp":1767607428000},"page":"167","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic Value and Metabolic Association of Serum Clusterin in Women with Polycystic Ovary Syndrome"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1492-0305","authenticated-orcid":false,"given":"Dilara Sar\u0131kaya","family":"Kurt","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Etlik City Hospital, Ankara 06170, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6570-1006","authenticated-orcid":false,"given":"Recep Taha","family":"A\u011fao\u011flu","sequence":"additional","affiliation":[{"name":"Department of Perinatology, Etlik City Hospital, Ankara 06170, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6798-4281","authenticated-orcid":false,"given":"Mehmet Ferdi","family":"K\u0131nc\u0131","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u0130zmir City Hospital, \u0130zmir 35400, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6416-7529","authenticated-orcid":false,"given":"Tu\u011f\u00e7e","family":"S\u0131rma","sequence":"additional","affiliation":[{"name":"Department of Gynecological Oncology Surgery, \u0130skenderun State Hospital, Hatay 31200, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8402-5675","authenticated-orcid":false,"given":"Ahmet","family":"Kurt","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Etlik City Hospital, Ankara 06170, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7183-4246","authenticated-orcid":false,"given":"Ramazan Erda","family":"Pay","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Etlik City Hospital, Ankara 06170, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3455-1719","authenticated-orcid":false,"given":"\u0130smail Burak","family":"G\u00fcltekin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Etlik City Hospital, Ankara 06170, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2268-3821","authenticated-orcid":false,"given":"H\u00fcseyin Levent","family":"Keskin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Etlik City Hospital, Ankara 06170, T\u00fcrkiye"},{"name":"Department of Obstetrics and Gynecology, School of Medicine, Ufuk University, Ankara 06510, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4418-7319","authenticated-orcid":false,"given":"Sezin Ert\u00fcrk","family":"Aksakal","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Etlik City Hospital, Ankara 06170, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"100619","DOI":"10.1016\/j.obmed.2025.100619","article-title":"Exploring female infertility: A comprehensive review of polycystic ovary syndrome (PCOS) and its impact on reproductive health","volume":"55","author":"Parua","year":"2025","journal-title":"Obes. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Dapas, M., Lin, F.T.J., Nadkarni, G.N., Sisk, R., Legro, R.S., Urbanek, M., Hayes, M.G., and Dunaif, A. (2020). Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis. PLoS Med., 17.","DOI":"10.1371\/journal.pmed.1003132"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","article-title":"Polycystic ovary syndrome","volume":"10","author":"Joham","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41574-024-01057-w","article-title":"Polycystic ovary syndrome as a metabolic disease","volume":"21","author":"Helvaci","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/humrep\/dew243","article-title":"Insulin resistance in polycystic ovary syndrome: A systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies","volume":"31","author":"Cassar","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Aboeldalyl, S., James, C., Seyam, E., Ibrahim, E.M., Shawki, H.E.-D., and Amer, S. (2021). The Role of Chronic Inflammation in Polycystic Ovarian Syndrome-A Systematic Review and Meta-Analysis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052734"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4579831","DOI":"10.1155\/2022\/4579831","article-title":"Role of Oxidative Stress in Obese and Nonobese PCOS Patients","volume":"2022","author":"Demir","year":"2022","journal-title":"Int. J. Clin. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s13668-023-00479-8","article-title":"Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review","volume":"12","author":"Cacciapuoti","year":"2023","journal-title":"Curr. Nutr. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment with Emphasis on Adolescent Girls","volume":"3","author":"Witchel","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"887","DOI":"10.7150\/ijms.107159","article-title":"Clusterin: Structure, function and roles in disease","volume":"22","author":"Du","year":"2025","journal-title":"Int. J. Med. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1161\/ATVBAHA.110.212894","article-title":"Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia","volume":"30","author":"Hoofnagle","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Won, J.C., Park, C.-Y., Oh, S.W., Lee, E.S., Youn, B.-S., and Kim, M.-S. (2014). Plasma clusterin (ApoJ) levels are associated with adiposity and systemic inflammation. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0103351"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Wittwer, J., and Bradley, D. (2021). Clusterin and Its Role in Insulin Resistance and the Cardiometabolic Syndrome. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.612496"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e230428","DOI":"10.1530\/EC-23-0428","article-title":"Increased GPC4 and clusterin associated with insulin resistance in patients with PCOS","volume":"13","author":"Chen","year":"2024","journal-title":"Endocr. Connect."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The Global Epidemic of the Metabolic Syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"R238","DOI":"10.1530\/EC-18-0129","article-title":"Cardiometabolic risk in polycystic ovary syndrome","volume":"7","author":"Pfeifer","year":"2018","journal-title":"Endocr. Connect."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4239\/wjd.v13.i3.129","article-title":"Markers of insulin resistance in Polycystic ovary syndrome women: An update","volume":"13","author":"Amisi","year":"2022","journal-title":"World J. Diabetes"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Prosperi, S., and Chiarelli, F. (2025). Insulin resistance, metabolic syndrome and polycystic ovaries: An intriguing conundrum. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1669716"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2337\/dc18-0870","article-title":"Clusterin Impairs Hepatic Insulin Sensitivity and Adipocyte Clusterin Associates with Cardiometabolic Risk","volume":"42","author":"Bradley","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"103530","DOI":"10.1016\/j.rbmo.2023.103530","article-title":"Determination of Clusterin level and its relation with metabolic syndrome in patients with polycystic ovary syndrome","volume":"47","author":"Asar","year":"2023","journal-title":"Reprod. Biomed. Online"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"616","DOI":"10.55214\/25768484.v8i5.1725","article-title":"The effect of Clusterin level as a potential marker in women with polycystic ovary syndrome","volume":"8","author":"Numan","year":"2024","journal-title":"Edelweiss Appl. Sci. Technol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/1\/167\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T10:17:40Z","timestamp":1767608260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/1\/167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["diagnostics16010167"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16010167","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]}}}